Hong Seng Consolidated Berhad (KLSE:HONGSENG) - Aandelenkoers, Nieuws & Analyse

HONGSENG Overzicht aandelen

Hong Seng Consolidated Berhad, een investeringsholding, houdt zich bezig met de productie van handschoenen en NBL, gezondheidszorg en financiële diensten in Maleisië en Australië.

Over het bedrijf

HONGSENG fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

Trading at 92.5% below our estimate of its fair value

Risicoanalyse

Highly volatile share price over the past 3 months compared to the MY market

Does not have a meaningful market cap (MYR77M)

Does not have meaningful revenue (MYR15M)

Hong Seng Consolidated Berhad Concurrenten

Smile-Link Healthcare Global Berhad

KLSE:SMILE

RM 36.6m

DC Healthcare Holdings Berhad

KLSE:DCHCARE

RM 164.4m

Optimax Holdings Berhad

KLSE:OPTIMAX

RM 353.1m

Metro Healthcare Berhad

KLSE:MHCARE

RM 388.5m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Hong Seng Consolidated Berhad
Historische aandelenkoersen
Huidige aandelenkoers	RM 0.015
52 Week Hoogtepunt	RM 0.055
52 Week Laag	RM 0.005
Bèta	1.97
11 maand verandering	0%
3 maanden verandering	50.00%
1 Jaar Verandering	-70.00%
33 jaar verandering	-99.15%
5 jaar verandering	-63.64%
Verandering sinds IPO	-74.77%

Recent nieuws en updates

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Sep 23

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Recent updates

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Sep 23

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

May 11

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Jan 27

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Jan 04

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Oct 26

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 31

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Aug 09

Rendement voor aandeelhouders

	HONGSENG	MY Healthcare	MY Markt
7D	0%	-2.9%	-0.8%
1Y	-70.0%	23.2%	10.4%

Rendement versus industrie: HONGSENG underperformed the MY Healthcare industry which returned 23.2% over the past year.

Rendement versus markt: HONGSENG underperformed the MY Market which returned 10.4% over the past year.

Prijsvolatiliteit

Is HONGSENG's price volatile compared to industry and market?
HONGSENG volatility
HONGSENG Average Weekly Movement	57.3%
Healthcare Industry Average Movement	4.1%
Market Average Movement	6.0%
10% most volatile stocks in MY Market	10.8%
10% least volatile stocks in MY Market	3.0%

Stabiele aandelenkoers: HONGSENG's share price has been volatile over the past 3 months compared to the MY market.

Volatiliteit in de loop van de tijd: HONGSENG's weekly volatility (57%) has been stable over the past year, but is still higher than 75% of MY stocks.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2001	321	n/a	www.hongseng.com.my

Hong Seng Consolidated Berhad, een beleggingsholding, houdt zich bezig met de productie van handschoenen en NBL, gezondheidszorg en financiële diensten in Maleisië en Australië. Het is actief in de segmenten gezondheidszorg, financiële diensten en handschoenen, zoek- en reclamediensten en andere. Het bedrijf biedt medische diagnostische en onderzoekslaboratoriumdiensten; groothandel in farmaceutische en medische producten; en geldleningsdiensten.

Hong Seng Consolidated Berhad Samenvatting

Hoe verhouden de winst en inkomsten van Hong Seng Consolidated Berhad zich tot de beurswaarde?
HONGSENG fundamentele statistieken
Marktkapitalisatie	RM 76.64m
Inkomsten(TTM)	-RM 61.22m
Inkomsten(TTM)	RM 14.95m

5.1x

P/S-verhouding

-1.3x

Koers/Winstverhouding

Is HONGSENG overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
HONGSENG resultatenrekening (TTM)
Inkomsten	RM 14.95m
Kosten van inkomsten	RM 37.58m
Brutowinst	-RM 22.63m
Overige uitgaven	RM 38.59m
Inkomsten	-RM 61.22m

Laatst gerapporteerde inkomsten

Mar 31, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.012
Brutomarge	-151.40%
Nettowinstmarge	-409.58%
Schuld/Eigen Vermogen Verhouding	3.8%

Hoe presteerde HONGSENG op de lange termijn?

Bekijk historische prestaties en vergelijking

HONGSENG Overzicht aandelen

Beloningen

Risicoanalyse

Hong Seng Consolidated Berhad Concurrenten

KLSE:SMILE

RM 36.6m

KLSE:DCHCARE

RM 164.4m

KLSE:OPTIMAX

RM 353.1m

KLSE:MHCARE

RM 388.5m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

High number of new directors

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Less than half of directors are independent

Hong Seng Consolidated Berhad Appoints Yacob Bin Mustafa as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Aug 29, 2024

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Recent updates

High number of new directors

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?

Less than half of directors are independent

Hong Seng Consolidated Berhad Appoints Yacob Bin Mustafa as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Aug 29, 2024

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

New major risk - Share price stability

Hong Seng Consolidated Berhad Announces Cessation of Teoh Soon Han as Alternate Director

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Hong Seng Consolidated Berhad Appoints Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

Hong Seng Consolidated Berhad entered into a Shares Sale Agreement to acquire Alliance EV Sdn Bhd from CSH Alliance Berhad for MYR 20 million.

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Hong Seng Consolidated Berhad agreed to acquire 51% stake in Innov8tif Holdings Sdn Bhd from Innov8tif Consortium Sdn Bhd for MYR 30.9 million.

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 27, 2023

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

High number of new and inexperienced directors

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Hong Seng Consolidated Berhad Appoints Tea Sor Hua as Company Secretary, Effective October 1, 2022

Hong Seng Consolidated Berhad Announces Re-Designation of Tuan Ng Keok Chai from Member of Remuneration Committee to Chairman of Remuneration Committee

Hong Seng Consolidated Berhad Appoints Dato Kang Chez Chiang as Independent and Non Executive Member of Nomination Committee

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Hong Seng Consolidated Berhad Reports Plant and Equipment Written Off for the Quarter Ended June 30, 2022

Third quarter 2022 earnings released: EPS: RM0.004 (vs RM0.013 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hong Seng Consolidated Berhad Appoints Dato Mohamed Suffian Bin Awang as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 25, 2022

Second quarter 2022 earnings: Revenues miss analyst expectations

Robust Potential Sdn Bhd entered into an agreement to acquire Hong Seng Priority Management Sdn Bhd from Hong Seng Consolidated Berhad (KLSE:HONGSENG) for MYR 34.5 million.

Senior Independent Non-Executive Director Mun Wong has left the company

Full year 2021 earnings released: EPS RM0.022 (vs RM0.025 loss in FY 2020)

Hong Seng Consolidated Berhad Announces Appointment of Mr. Christopher Chan Hooi Guan as Executive Director

Independent Non Executive Director has left the company

Hong Seng Consolidated Berhad Resigns Ym Tengku Farith Rithauddeen as Independent and Non Executive Independent Director

Hong Seng Consolidated Berhad Resigns Tengku Farith Rithauddeen as Independent and Non Executive Chairman of Nomination Committee

Third quarter 2021 earnings released: EPS RM0.006 (vs RM0.002 loss in 3Q 2020)

Hong Seng Consolidated Berhad Announces Resignation of Mr. Lim Peng Tong as Executive Director

New 90-day high: RM1.35

New 90-day high: RM1.15

Second quarter 2021 earnings released: EPS RM0.003

New 90-day low: RM0.99

Hong Seng Consolidated Berhad (KLSE:HONGSENG) entered into a share sale agreement to acquire remaining 49% stake in HS Bio Supplies Sdn Bhd from United ICT Consortium Sdn. Bhd. For MYR 0.98 million.

MSCM Holdings Berhad Announces Cessation of Wong Yee Ming as Non-Independent and Non-Executive Alternate Director

First quarter earnings released

New 90-day high - RM1.50